CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 48 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $305,000 | – | 11,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,425,225 | $197,871,000 | 2.50% |
| NEA Management Company, LLC | 2,141,697 | $40,649,000 | 1.68% |
| RA Capital Management | 585,403 | $11,111,000 | 0.93% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 862,279 | $16,366,000 | 0.62% |
| DAFNA Capital Management LLC | 60,000 | $1,139,000 | 0.61% |
| EcoR1 Capital, LLC | 194,166 | $3,685,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 163,000 | $3,094,000 | 0.36% |
| Rock Springs Capital Management LP | 345,000 | $6,548,000 | 0.30% |
| Birchview Capital, LP | 22,000 | $418,000 | 0.24% |
| SECTORAL ASSET MANAGEMENT INC | 75,313 | $1,429,000 | 0.18% |